Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe (-/-) mice

E. Di Marco, S. P. Gray, P. Chew, C. Koulis, A. Ziegler, C. Szyndralewiez, R. M. Touyz, H. H. H. W. Schmidt, M. E. Cooper, R. Slattery, K. A. Jandeleit-Dahm

Pharmacology and Personalised Medicine

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	633-642
Journal	Diabetologia
Volume	57
Issue number	3
DOIs	https://doi.org/10.1007/s00125-013-3118-3
Publication status	Published - Mar 2014

Keywords

Atherosclerosis
Diabetes
Immune system
Inflammation
NOX

Access to Document

10.1007/s00125-013-3118-3

Cite this

Di Marco, E., Gray, S. P., Chew, P., Koulis, C., Ziegler, A., Szyndralewiez, C., Touyz, R. M., Schmidt, H. H. H. W., Cooper, M. E., Slattery, R., & Jandeleit-Dahm, K. A. (2014). Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe (-/-) mice. Diabetologia, 57(3), 633-642. https://doi.org/10.1007/s00125-013-3118-3

Di Marco, E. ; Gray, S. P. ; Chew, P. ; Koulis, C. ; Ziegler, A. ; Szyndralewiez, C. ; Touyz, R. M. ; Schmidt, H. H. H. W. ; Cooper, M. E. ; Slattery, R. ; Jandeleit-Dahm, K. A. / Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe (-/-) mice. In: Diabetologia. 2014 ; Vol. 57, No. 3. pp. 633-642.

@article{251c3fff658b4b47abccbdbc04c0a62e,

title = "Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe (-/-) mice",

keywords = "Atherosclerosis, Diabetes, Immune system, Inflammation, NOX",

author = "{Di Marco}, E. and Gray, {S. P.} and P. Chew and C. Koulis and A. Ziegler and C. Szyndralewiez and Touyz, {R. M.} and Schmidt, {H. H. H. W.} and Cooper, {M. E.} and R. Slattery and Jandeleit-Dahm, {K. A.}",

year = "2014",

month = mar,

doi = "10.1007/s00125-013-3118-3",

language = "English",

volume = "57",

pages = "633--642",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer, Cham",

number = "3",

}

Di Marco, E, Gray, SP, Chew, P, Koulis, C, Ziegler, A, Szyndralewiez, C, Touyz, RM, Schmidt, HHHW, Cooper, ME, Slattery, R & Jandeleit-Dahm, KA 2014, 'Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe (-/-) mice', Diabetologia, vol. 57, no. 3, pp. 633-642. https://doi.org/10.1007/s00125-013-3118-3

Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe (-/-) mice. / Di Marco, E.; Gray, S. P.; Chew, P.; Koulis, C.; Ziegler, A.; Szyndralewiez, C.; Touyz, R. M.; Schmidt, H. H. H. W.; Cooper, M. E.; Slattery, R.; Jandeleit-Dahm, K. A.

In: Diabetologia, Vol. 57, No. 3, 03.2014, p. 633-642.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe (-/-) mice

AU - Di Marco, E.

AU - Gray, S. P.

AU - Chew, P.

AU - Koulis, C.

AU - Ziegler, A.

AU - Szyndralewiez, C.

AU - Touyz, R. M.

AU - Schmidt, H. H. H. W.

AU - Cooper, M. E.

AU - Slattery, R.

AU - Jandeleit-Dahm, K. A.

PY - 2014/3

Y1 - 2014/3

KW - Atherosclerosis

KW - Diabetes

KW - Immune system

KW - Inflammation

KW - NOX

U2 - 10.1007/s00125-013-3118-3

DO - 10.1007/s00125-013-3118-3

M3 - Article

C2 - 24292634

VL - 57

SP - 633

EP - 642

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 3

ER -